This report was recently updated on November 17 2024 with the latest and most recent
market numbers
Contrast Media Injection Sets Market Size, Trends & Analysis - Forecasts to 2026 By Product Type (Contrast Media Injection Sets with Bore Vented Tubing, Contrast Media Injection Sets with Vented Bifurcated Standard Bore, Contrast Media Injection Sets with a Vented Pressurized Spike and Others), By End Users (Hospitals, Cancer Research Institutes, and Diagnostic Imaging Centers), By Region (North America, Europe, Asia Pacific, MEA, and CSA) and Competitive Landscape
The global market will register a peak growth rate and continue the trend between 2021-2026. The major factors driving the market growth include rising investment and grants by the government; increasing prevalence of cancer and cardiovascular disease; contrast agents having a large number of approvals; and availability of IT-enabled solutions for contrast media injection sets among others.
Additionally, the contrast media injectors are used for injecting contrast agents or contrast media in the human body to enhance the blood as well as perfusion in tissues for the medical imaging procedure. These substances help in differentiating between different sets of tissues that have a similar composition. The contrast media injection sets play a vital role and are gaining attention in the emerging economies, due to the aging population and rising cancer cases. The contrast agents are normally used in small amounts for imaging which requires accurate dosage with a decent dose controlling system, therefore, the dose controlling system will also get affected because of the contrast media injection sets market.
Based on the product, the market can be explained into contrast media injection sets with a bore vented tubing, contrast media injection sets with a vented bifurcated standard bore, and contrast media injection sets with a vented pressurized spike among others. The contrast media injection sets with a bore vented tubing are estimated to be the dominating segment in the market. These products are widely adopted by professionals and they are easy to use compared to other product types.
Based on the end-user, the market is explained and divided into hospitals, cancer research institutes, and diagnostic imaging centers among others. The dominating segment in the market is expected to be the diagnostic imaging centers segment. The increased number of procedures, integrated with patient convenience, lack of imaging modalities in small and medium scale hospitals, and focus on innovations in the market are supporting the market growth. And, the hospital segment is also expected to have a large share in the market due to the increasing demand and adoption of minimally invasive procedures by patients in the hospitals as well as the increasing number of diagnostic imaging procedures performed in hospitals.
North America will dominate and hold maximum share in the market because of the increased number of nuclear imaging procedures, and the availability of high-end products. Whereas, Asia Pacific region is estimated to be the emerging market because of few emerging countries such as China and India, increasing aged population, rising cases of cancer, rising adoption of nuclear imaging techniques for diagnosis, and increasing government support for research work and better healthcare facilities.
The major players in the market of contrast media injection sets include Comed B.V., Ulrich Medical, Medtron AG, Smiths Medical, P R Medical, B. Braun, Apollo Rt Co. Ltd, Bayer, Nemoto Kyorindo Co. Ltd., Guerbet Group and among others. Bracco Imaging S.P.A, among others
Please note: This is not an exhaustive list of companies profiled in the report.
In February 2021, Bayer collaborated with Informed Data Systems, Inc. to develop digital products in the healthcare sector and innovations to help mankind.
In September 2019, Guerbet Group and IBM Watson Health collaborated to enhance the artificial intelligence-powered methods to diagnose and monitor cancer.
In February 2019, Bayer introduced the Medrad Centargo CT injection system as an addition to the CT injection segment of its imaging products.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Contrast Media Injection Sets Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Contrast Media Injection Sets Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
